Written by Dan Cripe, RN, BSN & Marcia Cripe, RN | Last Updated: September 13, 2026

How to Take Your First GLP-1 Injection: A Step-by-Step Administration Guide

Your first GLP-1 injection can feel much more complicated before you do it than it does afterward. You have medication you've never injected, several possible injection sites, instructions about storage and disposal, and the uncomfortable awareness that at some point you actually have to put a needle into your body.

The first thing to know is that not every GLP-1 injection comes in the same kind of device. You may have a prefilled autoinjector, a multidose pen that uses a disposable pen needle, a prefilled syringe, or medication in a vial that you draw into a separate syringe yourself.

Those differences matter because the medication may be administered the same general way—subcutaneously, into the fatty tissue beneath your skin—while the preparation and injection process can be completely different. A Wegovy autoinjector does not work like an Ozempic multidose pen, and neither works like drawing medication from a vial with a syringe.

You don't need to find the perfect injection time or the perfect first injection site. You do need to identify exactly which medication, concentration, dose, and delivery system you were prescribed before you begin.

First, Identify What You're Actually Injecting With

Before worrying about your stomach versus your thigh, look at the medication you received.

If you have an autoinjector, much of the injection process happens inside the device. Depending on the product, the needle may remain hidden before, during, and after administration.

If you have a multidose pen, you may need to attach a disposable pen needle, perform a device-specific flow check or priming procedure, select your prescribed dose, and then inject.

If you received a prefilled syringe, the medication has already been measured into the syringe. You still insert the needle yourself, but you generally aren't measuring medication from a vial.

And if you received a vial and separate syringe, you have an additional responsibility: measuring and withdrawing the correct volume before giving yourself the subcutaneous injection.

That last method deserves particular attention because the syringe markings represent volume, not automatically the medication dose in milligrams.

Before your first injection, read the Instructions for Use or pharmacy instructions supplied with your exact product. Confirm the medication name, prescribed dose, concentration when applicable, expiration date, and expected appearance of the solution.

If any of those pieces do not match what you were told to take, stop before injecting and contact the dispensing pharmacy or prescriber.

Pre-Injection Timing: Night vs. Morning

If you're wondering about the best time of day to take your first Ozempic shot, there isn't an FDA-designated best hour.

Ozempic can be administered once weekly at any time of day, with or without meals. Wegovy injection can likewise be administered at any time of day, and Zepbound does not require you to coordinate the weekly injection with a meal.

That makes morning versus evening primarily a practical decision rather than a medical requirement.

Morning may feel reassuring because you are awake and able to observe how you feel afterward. Evening may fit your routine better. Neither has been established as universally superior for preventing nausea or making the medication more effective.

You also don't need a special pre-injection meal, and you don't need to fast simply because you are taking the injection.

For your first dose, choose a time when you aren't rushed. Give yourself enough time to identify your device, read its instructions, prepare the medication correctly, and administer it without simultaneously trying to get out the door.

The day of the week will usually matter more than the hour because weekly GLP-1 medications are intended to be taken on a consistent weekly schedule.

Your First GLP-1 Injection: The Basic Sequence

The exact mechanics depend on your device, but the overall process is straightforward. Think of your first injection in this order:

1. Wash your hands and prepare a clean work area. Gather the medication, any required needle or syringe, supplies for cleaning the injection site, gauze if desired, and your sharps container before you begin.
2. Verify the medication and dose. Check the medication name, prescribed dose, expiration date, and appearance. If you're using medication from a vial, also verify the concentration and the volume you were instructed to withdraw.
3. Choose an approved injection site. Depending on your medication, this will usually include the abdomen, thigh, or upper arm. Follow the site diagram supplied with your product.
4. Prepare the injection site. Follow your product or clinician's cleaning instructions. If you use an alcohol swab, allow the skin to dry before injecting.
5. Prepare your device. This might mean removing the cap from an autoinjector, attaching a new needle and checking medication flow on a multidose pen, or drawing the prescribed volume from a vial.
6. Administer the injection according to your device's instructions. The correct angle, pressure, button sequence, skin-fold technique, and injection-completion signal vary by delivery system.
7. Make sure the dose has finished before removing the device. Don't rely on a generic rule such as “wait 10 seconds.” Follow the completion instructions for the specific device you're holding.
8. Dispose of the used sharp immediately. Place used needles, syringes, or disposable injection devices into an appropriate sharps container as directed.

That is the basic framework. The part that changes is what happens during Steps 5 through 7.

Selecting Your Injection Site: Abdomen vs. Thigh

For someone giving a GLP-1 injection for the first time, the abdomen and thigh are common approved options for subcutaneous GLP-1 administration.

There isn't a universal rule that your first injection should go into your stomach rather than your thigh.

Current instructions for commonly prescribed semaglutide and tirzepatide products identify approved subcutaneous regions that include the abdomen and thigh, with the upper arm also available for many products. Exact site instructions can differ by product and device, so use the diagram supplied with yours.

For your first injection, accessibility matters. Choose an approved area that you can comfortably see and reach while keeping the pen or syringe stable.

Avoid injecting into skin that is bruised, tender, red, hard, scarred, or otherwise irritated. If your product specifies a minimum distance from the belly button, follow that instruction.

Once you've chosen a region, don't repeatedly inject into exactly the same point. Rotate injection sites. You can return to the same general body region while choosing a different spot within it.

Pen Mechanics and Verifying Drug Flow

If you have an Ozempic multidose pen, you have a different process from someone using a single-dose autoinjector.

The phrase commonly used online is “priming an Ozempic pen,” although Novo Nordisk calls the procedure a flow check. The flow check is performed before the first injection with each new Ozempic pen rather than before every weekly injection from the same pen.

After attaching a new needle according to the manufacturer's instructions, you turn the dose selector to the flow-check symbol. With the needle pointing upward, you press and hold the dose button until the counter returns to zero. A drop at the needle tip verifies that medication can flow through the pen.

If the expected drop does not appear, follow the troubleshooting procedure in the Ozempic Instructions for Use rather than guessing that the pen is functioning correctly.

Most importantly, don't transfer the Ozempic procedure to another GLP-1 device. Some pens have different priming procedures, and single-dose autoinjectors operate differently.

Priming and flow checking are device instructions, not universal GLP-1 injection steps.

If You Have a Prefilled Autoinjector

Autoinjectors remove much of the needle handling and dose measurement from the process, but their operation still varies by product.

With the current Wegovy single-dose pen, for example, the needle is hidden. You press the pen firmly against your skin to begin the injection and maintain pressure until the device indicates that delivery is complete.

The Zepbound single-dose pen has its own activation method and completion signals.

This is why instructions such as “press the button,” “wait six seconds,” or “listen for two clicks” should never be treated as universal GLP-1 instructions. Those directions describe particular devices.

Read your device's instructions before removing caps or activating anything, position it against an approved injection site as directed, and keep it in place until that device's completion indicator tells you the dose has finished.

If Your GLP-1 Comes in a Vial: Drawing Up the Dose

If your medication comes in a vial, the most important part of your injection may happen before the needle ever touches your skin.

You have to withdraw the correct volume.

This is especially important with compounded GLP-1 medications because compounded products can be supplied in different concentrations. The number of milligrams contained in a particular volume therefore may not be the same from one pharmacy or formulation to another.

Never assume that the number of syringe “units” you used with a previous vial, another person's medication, or a dose you saw online applies to the vial currently in your hand.

Once your prescribed volume has been confirmed for your specific vial and syringe, the drawing-up process generally follows this sequence. Your pharmacy's instructions should take priority if they differ.

1. Read the vial label again. Confirm the medication, concentration, and prescribed volume before drawing anything into the syringe.
2. Inspect the medication. Follow the pharmacy's instructions regarding what the solution should look like and do not use it if its appearance falls outside those instructions.
3. Clean the vial stopper. If instructed, wipe the rubber stopper with an alcohol swab and allow it to dry.
4. Prepare a new sterile syringe and needle. Do not touch the needle or allow it to contact another surface.
5. Draw air into the syringe if instructed for your vial technique. The amount generally corresponds to the volume you plan to withdraw.
6. Insert the needle through the vial stopper and inject the air. Keep control of the syringe and vial throughout the process.
7. Turn the vial upside down while keeping the needle tip in the medication. Slowly withdraw the amount you were specifically instructed to use.
8. Check for significant air bubbles and verify the measurement. Follow the technique taught by your pharmacist or clinician to remove bubbles when necessary, then recheck where the plunger aligns with the syringe markings.
9. Verify the dose one final time before injecting. If the amount in the syringe doesn't match your instructions—or you aren't sure—stop here rather than estimating.

This is the vial equivalent of checking the dose window on a pen. The difference is that you are performing the measurement yourself, which makes that final check especially important.

Understanding “Units” on an Insulin Syringe

This deserves its own explanation because it is one of the most confusing parts of vial-based GLP-1 administration.

Many pharmacies supply small insulin-style syringes for subcutaneous injections because they make very small volumes easier to measure. Those syringes may be marked in units rather than milliliters.

On a standard U-100 insulin syringe, 100 syringe units correspond to 1 mL of volume. That means 10 syringe units represent 0.1 mL and 5 syringe units represent 0.05 mL.

But those syringe units describe volume. They do not tell you how many milligrams of semaglutide or tirzepatide are in that volume.

The medication concentration determines that.

This is precisely why copying another person's “20-unit dose” can be dangerous. Two vials containing the same medication can have different concentrations, meaning the same 20-unit volume could contain different amounts of active medication.

The FDA has documented patients who were supposed to administer 5 units but accidentally drew 50 units, resulting in a tenfold volume error. Other reported errors resulted in patients receiving five to 20 times the intended amount.

If your instructions tell you to inject a particular number of syringe units, make sure those instructions were written for your vial's concentration and your syringe. If the vial label, prescription directions, and syringe markings don't make sense together, do not try to calculate your way through the uncertainty.

Contact the dispensing pharmacy or prescriber and have them tell you exactly which line on your supplied syringe corresponds to your prescribed dose.

Needle Technique and Skin Pinching Protocols

If you're searching for how to inject Wegovy without pain, it is tempting to look for one universal needle technique.

There isn't one.

Whether you pinch your skin depends partly on the device and its instructions.

For the current Wegovy single-dose pen, the needle is hidden and the pen is pressed firmly against the skin according to the manufacturer's procedure. A prefilled syringe or traditional syringe can require a different technique because you control the needle yourself.

For a subcutaneous syringe injection, follow the technique taught by your pharmacist, nurse, or prescriber and the instructions supplied with your medication. Depending on needle length, body composition, injection site, and product instructions, that may involve gently gathering a fold of fatty tissue and inserting the needle at the instructed angle.

The goal is subcutaneous tissue—not muscle.

A brief pinch or sting can happen and does not mean the injection was performed incorrectly. Likewise, barely feeling the needle does not mean the medication failed to enter the tissue.

Giving the Injection With a Traditional Syringe

Once you've measured the correct dose and prepared the injection site, the actual injection is a relatively short sequence.

1. Check the syringe one last time. Confirm that the medication volume matches the instructions for your prescribed dose.
2. Hold the syringe securely without touching the needle. Position yourself so you can clearly see and comfortably reach the injection site.
3. Prepare the skin as instructed. If your technique calls for gently gathering a skin fold, do so without squeezing aggressively.
4. Insert the needle using the angle and technique appropriate for your syringe and instructions. Use a controlled motion rather than slowly pushing the needle against the skin.
5. Press the plunger steadily until the medication has been delivered. Avoid stopping halfway simply because you feel pressure or a mild sting.
6. Withdraw the needle and release the skin fold if you used one. If a tiny spot of blood appears, apply gentle pressure with clean gauze or a cotton ball rather than rubbing the site.
7. Place the entire used syringe directly into your sharps container. Do not recap, save, or reuse a disposable syringe.

Once the syringe is safely disposed of, the injection is finished.

Give Pens Enough Time to Finish

One of the easiest mistakes with a pen is becoming nervous and pulling it away too soon.

Different GLP-1 devices signal completion differently.

With the current Wegovy pen, you maintain pressure until the yellow bar has stopped moving. With the Zepbound single-dose pen, the manufacturer describes audible clicks and a visible plunger as indicators of injection progress and completion.

Ozempic's multidose pen works differently again. After its dose counter reaches zero, its Instructions for Use direct you to keep the dose button depressed and leave the needle in your skin while slowly counting for six seconds.

That is why you should not memorize a generic internet rule such as “hold every GLP-1 pen in place for 10 seconds.”

Learn your device's completion signal instead.

What If You See a Drop of Blood or Medication?

A tiny spot of blood can occur after a subcutaneous injection. Gentle pressure is usually sufficient.

A tiny drop remaining at the needle tip can also occur with some devices and does not necessarily mean you lost your dose.

A substantial amount of medication sitting on your skin is different. With certain autoinjectors, that can indicate that the device was removed too soon or wasn't held firmly enough against the skin.

If you're using a syringe and medication leaks back from the injection site, don't automatically assume the entire dose was lost.

Most importantly, do not give yourself another full injection simply because you aren't sure how much entered your body.

Doing so could turn an uncertain partial dose into an overdose. Contact your pharmacist, prescriber, or manufacturer for product-specific guidance.

The Extra Safety Issue With Compounded GLP-1 Vials

Compounded medication deserves a separate discussion because it creates an additional variable that a fixed-dose pen largely removes: you may be responsible for measuring the dose yourself.

Compounded drugs also do not undergo the same FDA premarket review for safety, effectiveness, and quality as FDA-approved medications.

That doesn't mean every person receiving a compounded medication will have a problem. It means you should not treat the vial as interchangeable with a branded pen—or even assume that one compounded vial is interchangeable with another.

The FDA has specifically warned about dosing errors involving compounded injectable semaglutide. Products have been supplied in different concentrations, different containers, and with instructions using milligrams, milliliters, or syringe units. Patients and healthcare professionals have made significant dosing errors while converting among those measurements.

If you receive a new vial and its concentration has changed, do not automatically draw to the same syringe line you used with the previous vial.

Check again.

Your prescription should give you enough information to know precisely how much medication you are administering. If it doesn't, the solution isn't to search social media for a conversion chart. Contact the pharmacy that compounded and dispensed that specific concentration.

Dispose of Every Needle Safely

Your injection isn't finished until the sharp is contained.

The FDA recommends placing used needles and other sharps into an FDA-cleared sharps disposal container immediately after use. If one isn't available, FDA guidance describes certain heavy-duty, puncture-resistant plastic household containers as potential alternatives when they meet appropriate requirements.

Don't place loose syringes or needles into household trash or recycling.

If you use a traditional syringe, dispose of the entire syringe appropriately after the injection. If you use a multidose pen with a detachable needle, follow the manufacturer's instructions for removing and disposing of that needle and storing the remaining pen.

Never save a disposable syringe for your next weekly injection.

What You May Feel After Your First Injection

Once the injection is finished, you don't need to sit and wait for something to happen.

You may notice absolutely nothing. You may eventually notice earlier fullness, reduced hunger, or a change in food noise. You may develop nausea, constipation, diarrhea, reflux, or another gastrointestinal effect.

But there is no requirement that you physically feel a GLP-1 medication begin working immediately.

That is especially important during starter doses. If you followed the administration instructions and have no evidence that the dose failed to deliver, the absence of an immediate sensation doesn't mean you injected incorrectly.

Your first dose begins treatment. It doesn't need to announce itself.

When an Injection Reaction Needs More Attention

Minor temporary tenderness is different from a substantial or worsening injection-site reaction.

Contact your healthcare provider if you develop significant redness, swelling, warmth, worsening pain, drainage, or another injection-site problem that concerns you.

Seek urgent medical attention for signs of a serious allergic reaction, including swelling of the face, lips, tongue, or throat; difficulty breathing or swallowing; severe rash or itching; fainting; or other rapidly developing severe symptoms.

Severe or persistent abdominal pain, repeated vomiting, inability to keep fluids down, or symptoms of significant dehydration also deserve medical evaluation rather than being dismissed as evidence that the medication is “working.”

Your First Injection Does Not Need to Be Perfect

The hardest part of your first GLP-1 injection may simply be doing something unfamiliar to your own body.

Once you understand your delivery system, the process becomes much less mysterious.

If you have a pen, learn that pen rather than memorizing generic injection advice. If you have a prefilled syringe, follow its specific technique. If you have a vial, learn both parts of the process: accurately measuring your prescribed dose and then administering a subcutaneous injection.

The most important rule with a vial is worth repeating: never guess at the dose conversion.

Milligrams tell you an amount of medication. Milliliters tell you a volume. Syringe units can be another way of marking volume. The concentration of the medication is what connects those measurements.

Once that part is clear, the physical injection itself is usually the simpler part.

Your first injection is not a test of whether you're “good at shots.” It is simply the first repetition of a routine that will probably feel far more ordinary once you've done it a few times.

Sources

1. U.S. Food and Drug Administration. FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products.
   https://www.fda.gov/drugs/human-drug-compounding/fda-alerts-health-care-providers-compounders-and-patients-dosing-errors-associated-compounded
2. U.S. Food and Drug Administration. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss.
   https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/medications-containing-semaglutide-marketed-type-2-diabetes-or-weight-loss
3. Novo Nordisk. Ozempic (semaglutide) Prescribing Information and Instructions for Use.
   https://www.novo-pi.com/ozempic.pdf
4. Novo Nordisk. Wegovy (semaglutide) Prescribing Information and Instructions for Use.
   https://www.novo-pi.com/wegovy.pdf
5. Eli Lilly and Company. Zepbound (tirzepatide) Prescribing Information and Instructions for Use.
   https://pi.lilly.com/us/zepbound-uspi.pdf
6. U.S. Food and Drug Administration. Safely Using Sharps (Needles and Syringes) at Home, at Work and on Travel.
   https://www.fda.gov/medical-devices/consumer-products/safely-using-sharps-needles-and-syringes-home-work-and-travel